application) The mechanisms of persistence of hepatitis C virus (HCV) infection are poorly understood, but the highly mutable viral genome offers a window on the natural history of this process. Whereas inadequate in vitro and animal models have hampered efforts to observe the virus more directly, sequence analysis has identified strains with higher pathogenic potential and resistance to pharmacologic treatment. It is not surprising that HCV sequences reveal clues to pathogenesis, because HCV exists in each infected host as a quasispecies. (a swarm of distinct but related variants), which is subject to Darwinian selection by the host's immune system. We have developed a method to identify distinct variants in each infected individual, allowing us to acquire an accurate nucleotide sequence sample of the quasispecies at greatly reduced cost. We also have access to specimens from ALIVE, a large cohort of injecting drug users, with clearly defined clinical and virologic outcomes. Our preliminary studies of acute infection suggest that self-limited viremia is associated with a less complex swarm of HCV variants, greater host selective pressure on more conserved regions (based on the ratio of within-quasispecies non-synonymous to synonymous diversity), and higher positive charge at the highly variable N-terminus of the envelope protein E2. Our central hypothesis is that an immune response directed against more conserved epitopes is associated with clearance of HCV viremia following acute infection. By testing this hypotheses in a well-characterized cohort with years of clinical and virologic data, we anticipate success in achieving greater understanding of antigenic variation as it relates to quasispecies diversity, and of the mechanisms of HCV persistence. Greater understanding of these aspects of HCV pathogenesis would have a significant impact on vaccine development and rational drug design. By combining our epidemiologic and molecular resources with novel tools, we aim to confirm and extend our preliminary observations by (1) studying a validation cohort, (2) collecting longitudinal sequence data, and (3) expanding the scope of the analysis to include more conserved regions of the HCV genome. This application is efficient and has a high likelihood of success because it makes use of a well-characterized cohort, for which years of clinical and virologic data have already been assembled.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK057998-05
Application #
6650151
Study Section
Special Emphasis Panel (ZDK1-GRB-5 (M1))
Program Officer
Doo, Edward
Project Start
1999-09-30
Project End
2005-08-31
Budget Start
2003-09-01
Budget End
2005-08-31
Support Year
5
Fiscal Year
2003
Total Cost
$343,379
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Wolfl, Matthias; Rutebemberwa, Alleluiah; Mosbruger, Timothy et al. (2008) Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire. J Immunol 181:6435-46
Cox, Andrea L; Mosbruger, Timothy; Lauer, Georg M et al. (2005) Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology 42:104-12
Laeyendecker, Oliver; Zhang, Guang Wen; Quinn, Thomas C et al. (2005) Molecular epidemiology of HIV-1 subtypes in southern China. J Acquir Immune Defic Syndr 38:356-62
Cox, Andrea L; Mosbruger, Timothy; Mao, Qing et al. (2005) Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 201:1741-52
Liu, Zhi; Netski, Dale M; Mao, Qing et al. (2004) Accurate representation of the hepatitis C virus quasispecies in 5.2-kilobase amplicons. J Clin Microbiol 42:4223-9
Thimme, R; Oldach, D; Chang, K M et al. (2001) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194:1395-406
Nousbaum, J; Polyak, S J; Ray, S C et al. (2000) Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy. J Virol 74:9028-38